Modugno F - Search Results

1

Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival.

Brieger KK, Peterson S, Lee AW, Mukherjee B, Bakulski KM, Alimujiang A, Anton-Culver H, Anglesio MS, Bandera EV, Berchuck A, Bowtell DDL, Chenevix-Trench G, Cho KR, Cramer DW, DeFazio A, Doherty JA, Fortner RT, Garsed DW, Gayther SA, Gentry-Maharaj A, Goode EL, Goodman MT, Harris HR, Høgdall E, Huntsman DG, Shen H, Jensen A, Johnatty SE, Jordan SJ, Kjaer SK, Kupryjanczyk J, Lambrechts D, McLean K, Menon U, Modugno F, Moysich K, Ness R, Ramus SJ, Richardson J, Risch H, Rossing MA, Trabert B, Wentzensen N, Ziogas A, Terry KL, Wu AH, Hanley GE, Pharoah P, Webb PM, Pike MC, Pearce CL; Ovarian Cancer Association Consortium. Brieger KK, et al. Among authors: modugno f. Gynecol Oncol. 2020 Sep;158(3):702-709. doi: 10.1016/j.ygyno.2020.06.481. Epub 2020 Jul 6. Gynecol Oncol. 2020. PMID: 32641237 Free PMC article.

2

Reproducibility in the assessment of postmenopausal ovaries with transvaginal ultrasound.

Modugno F, Weissfeld JL, Hill LM. Modugno F, et al. Gynecol Oncol. 2000 May;77(2):289-92. doi: 10.1006/gyno.2000.5785. Gynecol Oncol. 2000. PMID: 10785480

3

Cigarette smoking and the risk of mucinous and nonmucinous epithelial ovarian cancer.

Modugno F, Ness RB, Cottreau CM. Modugno F, et al. Epidemiology. 2002 Jul;13(4):467-71. doi: 10.1097/00001648-200207000-00016. Epidemiology. 2002. PMID: 12094103

4

Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma.

Sit AS, Modugno F, Weissfeld JL, Berga SL, Ness RB. Sit AS, et al. Among authors: modugno f. Gynecol Oncol. 2002 Aug;86(2):118-23. doi: 10.1006/gyno.2002.6746. Gynecol Oncol. 2002. PMID: 12144815

5

Effect of raloxifene on sexual function in older postmenopausal women with osteoporosis.

Modugno F, Ness RB, Ewing S, Cauley JA. Modugno F, et al. Obstet Gynecol. 2003 Feb;101(2):353-61. doi: 10.1016/s0029-7844(02)02589-9. Obstet Gynecol. 2003. PMID: 12576261 Clinical Trial.

6

Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States).

Modugno F, Moslehi R, Ness RB, Nelson DB, Belle S, Kant JA, Wheeler JE, Wonderlick A, Fishman D, Karlan B, Risch H, Cramer DW, Dube MP, Narod SA. Modugno F, et al. Cancer Causes Control. 2003 Jun;14(5):439-46. doi: 10.1023/a:1024932427503. Cancer Causes Control. 2003. PMID: 12946038

7

Ovarian cancer and high-risk women-implications for prevention, screening, and early detection.

Modugno F; Ovarian Cancer and High-Risk Women Symposium Presenters. Modugno F, et al. Gynecol Oncol. 2003 Oct;91(1):15-31. doi: 10.1016/s0090-8258(03)00254-3. Gynecol Oncol. 2003. PMID: 14529658 Review.

8

Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer.

Cottreau CM, Ness RB, Modugno F, Allen GO, Goodman MT. Cottreau CM, et al. Among authors: modugno f. Clin Cancer Res. 2003 Nov 1;9(14):5142-4. Clin Cancer Res. 2003. PMID: 14613992

9

Alcohol consumption and the risk of mucinous and nonmucinous epithelial ovarian cancer.

Modugno F, Ness RB, Allen GO. Modugno F, et al. Obstet Gynecol. 2003 Dec;102(6):1336-43. doi: 10.1016/j.obstetgynecol.2003.08.008. Obstet Gynecol. 2003. PMID: 14662224

10

Analysis of CHEK2 gene for ovarian cancer susceptibility.

Baysal BE, DeLoia JA, Willett-Brozick JE, Goodman MT, Brady MF, Modugno F, Lynch HT, Conley YP, Watson P, Gallion HH. Baysal BE, et al. Among authors: modugno f. Gynecol Oncol. 2004 Oct;95(1):62-9. doi: 10.1016/j.ygyno.2004.07.015. Gynecol Oncol. 2004. PMID: 15385111

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

315 results

Search Page

Filters